Our working groups conduct gap analysis to develop solutions and suggest actions based on shared goals to ensure that investment in priority research areas is balanced and coordinated, saving precious time and resources while avoiding duplication.
Together we are preparing the response to the next infectious disease outbreak.
GloPID-R facilitates coordination and information sharing among major global funding organizations through our working groups, guidance, tools, and multiple resources.
Our milestones
Preparedness
We analyze the current state of knowledge & preparedness for specific pathogens
GloPID-R establishes working relationships with key stakeholders and organizations during ‘peace time’ so that we are prepared to mount a coordinated response when an outbreak occurs.
Funding
We bring together major funders from across the globe
We do not fund projects directly.
Funding opportunities
Networking
We connect the global community of funders, researchers and policy makers
The COVID-19 pandemic has taught us that leveraging existing partnerships and funding greatly facilitates a rapid response.
Our working groups conduct gap analysis to develop solutions and suggest actions based on shared goals to ensure that investment in priority research areas is balanced and coordinated, saving precious time and resources while avoiding duplication.
In 2021 we began implementation of our regional hub strategy with a stronger focus on regional research priorities and capabilities. This new structure enables nimble coordination of research activities in preparedness and response by bridging gaps in the local research capacity. Each hub works in close coordination with the central secretariat to ensure alignment with the GloPID-R priorities.
Since 2013, our international network of research funders has been coordinating funders to improve preparedness and ensure a rapid research response wherever a severe outbreak strikes: Zika in Brazil, plague in Madagascar, Ebola in DRC, etc.
The GloPID-R Secretariat is a project which receives funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101094188.